Concomitant polymorphism is a widespread occurrence in industrial crystallization processes. A thorough understanding of this phenomenon is essential to prevent the emergence of undesirable polymorphs and ensure the production of high-quality products. In this study, the induction time method was employed to investigate the concomitant polymorphism phenomenon of risperidone in ethyl acetate. The impact of crystallization temperature and stirring rate on the concomitant polymorphism region was explored. Additionally, an analysis of the nucleation tendencies of risperidone form I and form II was conducted from both thermodynamic and kinetic perspectives. Based on the induction time theory, the nucleation parameters of form I and form II were calculated. Through an examination of the change in these nucleation parameters with supersaturation, a comprehensive explanation was provided for the reasons behind the occurrence of concomitant polymorphism and the nucleation behavior of form I and form II under varying degrees of supersaturation. Moreover, the concomitant polymorphism phenomenon during the slow-cooling crystallization process was investigated, and the relationship between operational conditions and the concomitant polymorphism region was discussed.